Literature DB >> 22513990

Magnesium intake is not related to depression risk in Spanish university graduates.

Marie-Laure Derom1, Miguel A Martínez-González, Maria del Carmen Sayón-Orea, Maira Bes-Rastrollo, Juan J Beunza, Almudena Sánchez-Villegas.   

Abstract

Magnesium is the second most predominant intracellular cation and it is an important cofactor in over 300 enzymatic reactions. It is a calcium antagonist and a voltage-dependent blocker of the N-methyl-D-aspartate channel, which plays a role in the entrance of calcium into the neuron. Other mechanisms also add biological plausibility to neuro-protective properties for magnesium, including an inverse association with major depression. A higher magnesium intake has been related to lower depressive symptoms. However, epidemiological evidence on this issue is scarce. Our aim was to prospectively evaluate the association between dietary magnesium intake and depression incidence in a cohort of 12,939 Spanish university graduates initially free of depression (Seguimiento Universidad de Navarra Cohort Study). Total magnesium intake was assessed with a validated, semiquantitative FFQ and incident depression was ascertained through self-reports of a new clinical diagnosis of depression done by a medical doctor and/or the habitual use of antidepressive drugs. The self-report was validated against the Diagnostic and Statistical Manual of Mental Disorders (4th edition) criteria in a subsample of the cohort. Cox regression models were used to obtain HR of incident depression during follow-up according to baseline quintiles of magnesium intake using the lowest quintile as the reference category. After a median follow-up of 6.3 y, 737 new cases of depression were identified. No association between magnesium intake and depression was found, with multivariate-adjusted HR = 1 (reference), 1.00 (95% CI: 0.78-1.27), 1.00 (0.76-1.31), 0.95 (0.70-1.30), and 1.11 (0.77-1.59) for increasing categories (quintiles 1-5) of total magnesium intake. No dose-response relationship was found (P-trend = 0.59). Results were robust through different sensitivity analyses, including nutrient density or residual models. In conclusion, our findings do not suggest an inverse association between magnesium intake and depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513990     DOI: 10.3945/jn.111.155572

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

1.  Micronutrient intake adequacy and depression risk in the SUN cohort study.

Authors:  Almudena Sánchez-Villegas; Aurora Pérez-Cornago; Itziar Zazpe; Susana Santiago; Francisca Lahortiga; Miguel Angel Martínez-González
Journal:  Eur J Nutr       Date:  2017-09-04       Impact factor: 5.614

2.  Magnesium intake was inversely associated with hostility among American young adults.

Authors:  Chen Lyu; Cari L Tsinovoi; Pengcheng Xun; Yiqing Song; Yongjia Pu; Andrea Rosanoff; Carlos Iribarren; Pamela J Schreiner; James M Shikany; David R Jacobs; Ka Kahe
Journal:  Nutr Res       Date:  2021-04-21       Impact factor: 3.315

3.  A longitudinal analysis of diet quality scores and the risk of incident depression in the SUN Project.

Authors:  Almudena Sánchez-Villegas; Patricia Henríquez-Sánchez; Miguel Ruiz-Canela; Francisca Lahortiga; Patricio Molero; Estefanía Toledo; Miguel A Martínez-González
Journal:  BMC Med       Date:  2015-09-17       Impact factor: 8.775

4.  Role of magnesium supplementation in the treatment of depression: A randomized clinical trial.

Authors:  Emily K Tarleton; Benjamin Littenberg; Charles D MacLean; Amanda G Kennedy; Christopher Daley
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

5.  Correlation of Ionized Magnesium with the Parameters of Oxidative Stress as Potential Biomarkers in Patients with Anxiety and Depression: A Pilot Study.

Authors:  Ana Opanković; Srđan Milovanović; Branimir Radosavljević; Milena Čavić; Irina Besu Žižak; Zoran Bukumirić; Milan Latas; Branislava Medić; Sonja Vučković; Dragana Srebro; Katarina Savić Vujović
Journal:  Dose Response       Date:  2022-07-21       Impact factor: 2.623

6.  Low dietary calcium is associated with self-rated depression in middle-aged Korean women.

Authors:  Yun-Jung Bae; Soon-Kyung Kim
Journal:  Nutr Res Pract       Date:  2012-12-31       Impact factor: 1.926

7.  A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Authors:  M S Milak; C J Proper; S T Mulhern; A L Parter; L S Kegeles; R T Ogden; X Mao; C I Rodriguez; M A Oquendo; R F Suckow; T B Cooper; J G Keilp; D C Shungu; J J Mann
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

Review 8.  Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications.

Authors:  Jessica Wang; Phoebe Um; Barbra A Dickerman; Jianghong Liu
Journal:  Nutrients       Date:  2018-05-09       Impact factor: 5.717

9.  Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.

Authors:  Matthew S Milak; Rain Rashid; Zhengchao Dong; Lawrence S Kegeles; Michael F Grunebaum; R Todd Ogden; Xuejing Lin; Stephanie T Mulhern; Raymond F Suckow; Thomas B Cooper; John G Keilp; Xiangling Mao; Dikoma C Shungu; J John Mann
Journal:  JAMA Netw Open       Date:  2020-08-03

10.  Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.

Authors:  Beata Ryszewska-Pokraśniewicz; Anna Mach; Michał Skalski; Piotr Januszko; Zbigniew M Wawrzyniak; Ewa Poleszak; Gabriel Nowak; Andrzej Pilc; Maria Radziwoń-Zaleska
Journal:  Nutrients       Date:  2018-08-03       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.